TARGET-BASED METHOD FOR HIGH-THROUGHPUT AND SUBCLASS SPECIFIC IgG GLYCAN PROFILING IN HUMAN PLASMA
US-2024353417-A1 · Oct 24, 2024 · US
US11802879B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11802879-B2 |
| Application number | US-201716080903-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 2, 2017 |
| Priority date | Mar 2, 2016 |
| Publication date | Oct 31, 2023 |
| Grant date | Oct 31, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to a streamlined, complete workflow for the qualitative and the quantitative analysis of conjugated peptides from antibody-drug conjugate (ADC) compounds.
Opening claim text (preview).
We claim: 1. A method for analyzing site occupancy ratios in antibody-drug conjugates, said method comprising: (i) providing a sample comprising an antibody-drug conjugate compound; (ii) exposing the sample to de-salting; (iii) exposing the sample to multienzyme digestion to form a digested peptide mixture, wherein the digested peptide mixture comprises conjugated peptide and unconjugated peptide; (iv) ionizing the sample to form radical ion fragments; (v) detecting the mass-to-charge ratios associated with the radical ion fragments; (vi) analyzing the mass-to-charge ratios of the radical ion fragments; and (vii) quantifying the site occupancy ratio in the sample by determining the ratio of conjugated peptide to conjugated peptide and unconjugated peptide, thereby analyzing site occupancy ratios in antibody-drug conjugates. 2. The method of claim 1 , further comprising identifying the conjugated peptide and unconjugated peptide in the sample. 3. The method of claim 1 , further comprising selecting two separate groups of mass-to-charge ratios of the radical ion fragments. 4. The method of claim 3 , wherein the first group of mass-to-charge ratios is associated with the radical ion fragments of the conjugated peptide. 5. The method of claim 3 , wherein the second group of mass-to-charge ratios is associated with the radical ion fragments of the unconjugated peptide. 6. The method of claim 3 , wherein the selection of the two separate groups of mass-to-charge ratios is based on known ion fragmentation patterns. 7. The method of claim 6 , wherein the known ion fragmentation patterns are stored in a library. 8. The method of claim 1 , wherein the multienzyme digestion comprises a first enzyme and a second enzyme. 9. The method of claim 8 , wherein the first enzyme is trypsin/Lys C. 10. The method of claim 9 , wherein the ratio of the trypsin/Lys C to sample is about 1:25 (w/w). 11. The method of claim 8 , wherein the second enzyme is Asp N. 12. The method of claim 11 , wherein the ratio of the Asp N to sample is about 1:100 (w/w).
Methods of protein analysis involving mass spectrometry · CPC title
Mass spectrometers {(mass spectrometers per se H01J49/00)} · CPC title
interfaced to liquid or supercritical fluid chromatograph (interfaces in general for introducing or extracting samples to be analysed with specially adapted mass spectrometer, see H01J49/04) · CPC title
Liquid chromatography · CPC title
Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.